Exact Sciences (EXAS) Reports Q4 Loss of $86M, Misses EPS Expectations

Exact Sciences Corp. (EXAS) reported a fourth-quarter loss of $86 million, or 45 cents per share, with adjusted non-GAAP loss at 21 cents per share. Results missed Wall Street expectations; the average of four Zacks analyst estimates was breakeven on a per-share basis. Revenue for the quarter totaled $878.4 million, exceeding forecasts of $860.6 million. Year-over-year, the company posted a loss of $207.9 million, or $1.10 per share, with revenue of $3.25 billion.